美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aardvark Therapeutics

10.43

+0.51005.14%

成交量：10.71万

成交额：111.31万

市值：2.26亿

市盈率：-16.10

高：10.94

开：9.97

低：9.92

收：9.92

52周最高：19.58

52周最低：4.88

股本：2,169.69万

流通股本：588.80万

量比：1.71

换手率：1.82%

股息：- -

股息率：- -

每股收益(TTM):-0.6480

每股收益(LYR):-0.7400

净资产收益率：-33.09%

总资产收益率：-21.76%

市净率：1.65

市盈率(LYR):-14.09

数据加载中...

总览公司新闻资讯公告

Aardvark Therapeutics宣布FDA就扩大针对普拉德-威利综合征的三期Hero试验人群的协议修订达成一致

美国研究综述-Carvana、Marvell Technology、Wayfair

美国研究综述-Carvana、Marvell Technology、Wayfair

LB 制药公司在美国首次公开募股中筹资 2.85 亿美元

生物技术行业陷入困境，LB Pharmaceuticals 着眼于 3.22 亿美元的首次公开募股估值

Aardvark Therapeutics, Inc.2025财年第一财季实现净利润-9.31百万美元，同比减少327.06%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/AARD/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AARD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AARD\",,,,,undefined,":{"symbol":"AARD","market":"US","secType":"STK","nameCN":"Aardvark Therapeutics","latestPrice":10.43,"timestamp":1763403715232,"preClose":9.92,"halted":0,"volume":107096,"delay":0,"floatShares":5888000,"shares":21696893,"eps":-0.648,"marketStatus":"交易中","change":0.51,"latestTime":"11-17 13:22:16 EST","open":9.97,"high":10.94,"low":9.9201,"amount":1113068.112376,"amplitude":0.102812,"askPrice":10.51,"askSize":300,"bidPrice":10.42,"bidSize":206,"shortable":0,"etf":0,"ttmEps":-0.648,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1763413200000},"marketStatusCode":2,"adr":0,"listingDate":1739509200000,"exchange":"NASDAQ","adjPreClose":9.92,"postHourTrading":{"tag":"盘后","latestPrice":9.92,"preClose":9.92,"latestTime":"19:03 EST","volume":195,"amount":1940.82,"timestamp":1763165020843},"volumeRatio":1.71131},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AARD\",,,,,undefined,":{"symbol":"AARD","floatShares":5888000,"roa":"-21.76%","roe":"-33.09%","lyrEps":-0.74,"volumeRatio":1.71131,"shares":21696893,"dividePrice":0,"high":10.94,"amplitude":0.102812,"preClose":9.92,"low":9.9201,"week52Low":4.88,"pbRate":"1.65","week52High":19.58,"institutionHeld":0,"latestPrice":10.43,"committee":-0.185771,"eps":-0.648,"divideRate":0,"volume":107096,"delay":0,"ttmEps":-0.648,"open":9.97,"prevYearClose":16,"prevWeekClose":9.92,"prevMonthClose":10.69,"prevQuarterClose":13.29,"fiveDayClose":10.44,"twentyDayClose":12.28,"sixtyDayClose":9.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AARD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"AARD","fiscalQuarterEnding":"2025/09","expectedEps":-0.82,"name":null,"time":"盘后","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.75},{"market":"US","date":"2025-08-13","symbol":"AARD","fiscalQuarterEnding":"2025/06","expectedEps":-0.52,"name":null,"time":"盘后","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2025-05-14","symbol":"AARD","fiscalQuarterEnding":"2025/03","expectedEps":-0.7,"name":null,"time":"盘后","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2025-03-31","symbol":"AARD","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AARD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AARD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AARD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AARD","date":"2025-11-14","current":-15.308642,"percent":0.819149,"low":-51.17654,"twenty":-11.527382,"median":-8.978494,"eighty":-6.599437,"high":-4.61321,"avg":-12.415283,"sd":9.740001,"marketCap":236457733},"quantilePoints":[{"date":"2025-02-21","current":-51.17654,"twenty":-46.993414,"median":-42.216938,"eighty":-39.920668,"marketCap":368880503},{"date":"2025-02-28","current":-39.75453,"twenty":-42.139802,"median":-40.229211,"eighty":-39.232381,"marketCap":286550651},{"date":"2025-03-07","current":-28.243517,"twenty":-40.603022,"median":-39.176012,"eighty":-36.900511,"marketCap":203579269},{"date":"2025-03-14","current":-31.091602,"twenty":-40.336014,"median":-37.766803,"eighty":-30.723725,"marketCap":224108270},{"date":"2025-03-21","current":-27.23482,"twenty":-39.944402,"median":-34.681377,"eighty":-29.198812,"marketCap":196308580},{"date":"2025-03-28","current":-26.404128,"twenty":-39.576524,"median":-30.913597,"eighty":-27.946841,"marketCap":190320955},{"date":"2025-04-04","current":-9.026143,"twenty":-39.119644,"median":-30.068072,"eighty":-27.341623,"marketCap":185830236},{"date":"2025-04-11","current":-7.397773,"twenty":-38.751766,"median":-29.400552,"eighty":-17.252871,"marketCap":152305358},{"date":"2025-04-17","current":-7.977371,"twenty":-38.300819,"median":-28.45119,"eighty":-8.603741,"marketCap":164238114},{"date":"2025-04-25","current":-8.66235,"twenty":-37.766803,"median":-27.946841,"eighty":-8.371497,"marketCap":178340462},{"date":"2025-05-02","current":-11.939711,"twenty":-36.900511,"median":-27.412825,"eighty":-8.371497,"marketCap":245814773},{"date":"2025-05-09","current":-11.307423,"twenty":-34.865316,"median":-26.68597,"eighty":-8.46634,"marketCap":232797221},{"date":"2025-05-16","current":-7.114571,"twenty":-32.693651,"median":-13.552046,"eighty":-8.46634,"marketCap":197215912},{"date":"2025-05-23","current":-7.834638,"twenty":-31.0204,"median":-11.823792,"eighty":-8.360959,"marketCap":217176159},{"date":"2025-05-30","current":-8.061615,"twenty":-30.818661,"median":-11.433881,"eighty":-8.172533,"marketCap":223467976},{"date":"2025-06-06","current":-9.353039,"twenty":-30.367714,"median":-11.107198,"eighty":-8.178795,"marketCap":259266244},{"date":"2025-06-13","current":-8.656453,"twenty":-30.076972,"median":-10.833207,"eighty":-8.210998,"marketCap":239956875},{"date":"2025-06-20","current":-9.454788,"twenty":-30.053238,"median":-10.188135,"eighty":-8.218152,"marketCap":262086713},{"date":"2025-06-27","current":-10.84796,"twenty":-29.697227,"median":-10.664596,"eighty":-8.356744,"marketCap":300705451},{"date":"2025-07-03","current":-10.894921,"twenty":-29.459887,"median":-10.613156,"eighty":-8.365174,"marketCap":302007206},{"date":"2025-07-11","current":-9.861782,"twenty":-29.308323,"median":-10.597502,"eighty":-8.375712,"marketCap":273368592},{"date":"2025-07-18","current":-9.360866,"twenty":-28.618005,"median":-10.433139,"eighty":-8.40036,"marketCap":259483203},{"date":"2025-07-25","current":-10.542714,"twenty":-28.285052,"median":-10.45662,"eighty":-8.474871,"marketCap":292244042},{"date":"2025-08-01","current":-9.4,"twenty":-28.006176,"median":-10.433139,"eighty":-8.577715,"marketCap":260567999},{"date":"2025-08-08","current":-9.368693,"twenty":-27.946841,"median":-10.061366,"eighty":-8.607418,"marketCap":259700162},{"date":"2025-08-15","current":-6.668132,"twenty":-27.567096,"median":-9.861782,"eighty":-8.474871,"marketCap":244307015},{"date":"2025-08-22","current":-5.762071,"twenty":-27.424692,"median":-9.803081,"eighty":-8.329026,"marketCap":211110768},{"date":"2025-08-29","current":-5.027748,"twenty":-27.270421,"median":-9.525229,"eighty":-8.145134,"marketCap":184206621},{"date":"2025-09-05","current":-5.027748,"twenty":-27.074615,"median":-9.478268,"eighty":-8.014507,"marketCap":184206621},{"date":"2025-09-12","current":-4.61321,"twenty":-26.629602,"median":-9.396086,"eighty":-7.797069,"marketCap":169018796},{"date":"2025-09-19","current":-6.685898,"twenty":-23.929853,"median":-9.368693,"eighty":-7.515801,"marketCap":244957921},{"date":"2025-09-26","current":-7.503129,"twenty":-17.043362,"median":-9.298251,"eighty":-7.308831,"marketCap":274899634},{"date":"2025-10-03","current":-9.102059,"twenty":-12.821851,"median":-9.210333,"eighty":-7.389343,"marketCap":333481245},{"date":"2025-10-10","current":-9.824539,"twenty":-12.161077,"median":-9.298251,"eighty":-7.460987,"marketCap":359951454},{"date":"2025-10-17","current":-7.876213,"twenty":-12.040618,"median":-9.212156,"eighty":-7.503145,"marketCap":288568676},{"date":"2025-10-24","current":-6.425331,"twenty":-11.978881,"median":-9.149542,"eighty":-7.334887,"marketCap":235411289},{"date":"2025-10-31","current":-6.194375,"twenty":-11.800608,"median":-9.102059,"eighty":-7.096882,"marketCap":226949500},{"date":"2025-11-07","current":-5.844979,"twenty":-11.619352,"median":-9.083015,"eighty":-6.739195,"marketCap":214148333},{"date":"2025-11-14","current":-6.453893,"twenty":-11.527382,"median":-8.978494,"eighty":-6.599437,"marketCap":236457733}],"updateTime":1763383910631},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AARD\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1194886481","title":"Aardvark Therapeutics宣布FDA就扩大针对普拉德-威利综合征的三期Hero试验人群的协议修订达成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1194886481","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194886481?lang=zh_cn&edition=fundamental","pubTime":"2025-10-08 20:02","pubTimestamp":1759924977,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics宣布FDA就扩大针对普拉德-威利综合征的三期Hero试验人群的协议修订达成一致","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"gpt_icon":0},{"id":"2572894145","title":"美国研究综述-Carvana、Marvell Technology、Wayfair","url":"https://stock-news.laohu8.com/highlight/detail?id=2572894145","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572894145?lang=zh_cn&edition=fundamental","pubTime":"2025-10-01 15:33","pubTimestamp":1759304017,"startTime":"0","endTime":"0","summary":"美国研究综述-Carvana、Marvell Technology、Wayfair路透社10月1日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Carvana、Marvell Technology 和 Wayfair。* Marvell Technology Inc MRVL.O：TD Cowen 将其评级从买入下调至持有 * Pool Corp POOL.O：KeyBanc将其评级从行业权重调高至 \"买入\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nL3S3VI0GJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BILL","HHH","NAVI","CPAY","MQ","ALLY","OMC","CVNA","AXSM","AXP","LIF","SYF","FOUR","BFH","BLDR","EEFT","SMTC","BWIN","FIS","MRVL","IPG","WU","LW","BRO","DEI","PTGX","AARD","TOST","MRCY","LU0130102774.USD","MMC","ADSK","HROW","UPWK","ZYME","CHYM","BSX","POOL","MTSI","AJG","SLM","ZETA","JKHY","PAYX","PDM","ARCB"],"gpt_icon":1},{"id":"2572589411","title":"美国研究综述-Carvana、Marvell Technology、Wayfair","url":"https://stock-news.laohu8.com/highlight/detail?id=2572589411","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572589411?lang=zh_cn&edition=fundamental","pubTime":"2025-10-01 15:33","pubTimestamp":1759304017,"startTime":"0","endTime":"0","summary":"美国研究综述-Carvana、Marvell Technology、Wayfair路透社10月1日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Carvana、Marvell Technology 和 Wayfair。* Marvell Technology Inc MRVL.O：TD Cowen 将其评级从买入下调至持有 * Pool Corp POOL.O：KeyBanc将其评级从行业权重调高至 \"买入\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nL3T3VI0GJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCB","SLM","OMC","LU0130102774.USD","ADSK","CPAY","MQ","MRCY","DEI","HROW","ALLY","WU","BWIN","EEFT","MMC","BLDR","NAVI","LIF","MRVL","AXP","TOST","ZETA","ZYME","SYF","BSX","IPG","AXSM","AARD","AJG","POOL","FIS","JKHY","MTSI","CHYM","HHH","LW","BFH","PTGX","FOUR","PAYX","CVNA","SMTC","UPWK","PDM","BRO","BILL"],"gpt_icon":1},{"id":"2566931627","title":"LB 制药公司在美国首次公开募股中筹资 2.85 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566931627","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566931627?lang=zh_cn&edition=fundamental","pubTime":"2025-09-11 09:18","pubTimestamp":1757553531,"startTime":"0","endTime":"0","summary":"更新版 1-LB 制药公司在美国首次公开募股中筹资 2.85 亿美元从第 2 段起增加详细信息路透社9月11日 - LB Pharmaceuticals 生物技术公司周三表示，该公司在美国首次公开募股中筹集了 2.85 亿美元，这是自 2 月份以来生物技术公司首次大规模公开募股。此次 IPO 对 LB 公司的估值为 3.015 亿美元。该公司股价自2月份上市以来已下跌近一半。该公司计划在 2026 年第一季度开始对急性精神分裂症患者进行为期六周的 LB-102 晚期试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nL3S3UY031:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SF","BK4127","AARD","BK4207","PIPR","MNSH"],"gpt_icon":0},{"id":"2565680373","title":"生物技术行业陷入困境，LB Pharmaceuticals 着眼于 3.22 亿美元的首次公开募股估值","url":"https://stock-news.laohu8.com/highlight/detail?id=2565680373","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565680373?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 22:37","pubTimestamp":1757342235,"startTime":"0","endTime":"0","summary":"生物技术行业陷入困境，LB Pharmaceuticals 着眼于 3.22 亿美元的首次公开募股估值路透社9月8日 - 资金短缺的药物开发商 LB Pharmaceuticals周一表示，其纽约首次公开募股的目标估值将高达 3.216 亿美元，这可能是几个月来美国生物技术公司首次大规模上市。公司背景 LB Pharmaceuticals 公司成立于 2015 年，目前正在开发针对精神分裂症、双相抑郁症和其他神经精神疾病的疗法。下一步计划LB Pharmaceuticals 将在纳斯达克上市，股票代码为 \"LBRX\"。Leerink Partners、Piper Sandler 和 Stifel 是此次发行的主承销商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nL3S3UV13A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SF","AARD","PIPR","BK4127","MNSH","BK4207"],"gpt_icon":0},{"id":"2537199923","title":"Aardvark Therapeutics, Inc.2025财年第一财季实现净利润-9.31百万美元，同比减少327.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537199923","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537199923?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 00:00","pubTimestamp":1747929643,"startTime":"0","endTime":"0","summary":"5月23日，Aardvark Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为-9.31百万美元，同比减少327.06%；其中营业收入为0.00美元，每股基本收益为-0.43美元。从资产负债表来看，Aardvark Therapeutics, Inc.总负债6.34百万美元，其中短期债务390000.00美元，资产负债比为0.25，流动比率为0.26。机构评级：截至2025年5月23日，当前有4家机构对Aardvark Therapeutics, Inc.目标价做出预测，其中目标均价为31.25美元，其中最低目标价为20.00美元，最高目标价为50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000247a4887759&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000247a4887759&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AARD","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}